Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 2 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
New COVID-19 FLiRT variants are now the dominant variant. Could there be a summer surge?
USA TODAY via Yahoo News· 3 hours agoSymptoms may appear two to 14 days after exposure. Latest COVID guidance from the CDC In March 2024, the CDC updated its COVID-19 guidance ...
Earnings call: Atea Pharmaceuticals reports progress in COVID-19 trial By Investing.com
Investing.com· 8 hours agoThe company reported the completion of patient enrollment ahead of schedule for its SUNRISE-3 global...
PowerBand Provides Bi-Weekly MCTO Status Update
Digital Journal· 3 hours agoThe forward...
A tale of two nurses: How average travel nurse compensation compares to all US nurse salaries
Stacker via AOL· 20 hours agoShutterstock // Gorodenkoff Heightened demand made nursing a high-paying profession over the last...
Trade and investment data in the last two years dispel the deglobalization and decoupling myths as...
Fortune via Yahoo Finance· 5 hours agoReaching back to Joseph Stiglitz’s 2002 best-seller Globalization and Its Discontents, a stream of...
California’s budget deficit has grown. Here’s how Gov. Newsom is responding
Los Angeles Times· 1 day agoGov. Gavin Newsom released his revised $288-billion budget proposal last week, which included a...
UPDATE: NWS confirms tornado; governor says state working with parishes
KATC 3 Lafayette· 1 day agoUPDATE: Scientists with the National Weather Service have confirmed that it was a tornado that...
Earnings call: CoreCivic outlines revenue growth and updated guidance for 2024 By Investing.com
Investing.com· 6 days agoCoreCivic, Incorporated (NYSE:CXW) has reported a 9% increase in revenue for the first quarter of...
Atea Pharmaceuticals Inc (AVIR) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress ...
GuruFocus.com via Yahoo Finance· 3 hours agoPositive Points Atea Pharmaceuticals Inc (NASDAQ:AVIR) has successfully completed enrollment for the SUNRISE three global Phase three trial for COVID-19 ...